275 related articles for article (PubMed ID: 35215916)
61. Infectious viral shedding of SARS-CoV-2 Delta following vaccination: A longitudinal cohort study.
Garcia-Knight M; Anglin K; Tassetto M; Lu S; Zhang A; Goldberg SA; Catching A; Davidson MC; Shak JR; Romero M; Pineda-Ramirez J; Diaz-Sanchez R; Rugart P; Donohue K; Massachi J; Sans HM; Djomaleu M; Mathur S; Servellita V; McIlwain D; Gaudiliere B; Chen J; Martinez EO; Tavs JM; Bronstone G; Weiss J; Watson JT; Briggs-Hagen M; Abedi GR; Rutherford GW; Deeks SG; Chiu C; Saydah S; Peluso MJ; Midgley CM; Martin JN; Andino R; Kelly JD
PLoS Pathog; 2022 Sep; 18(9):e1010802. PubMed ID: 36095030
[TBL] [Abstract][Full Text] [Related]
62. Impact of time elapsed since full vaccination on SARS-CoV-2 RNA load in Delta-variant breakthrough COVID-19.
de Michelena P; Torres I; Albert E; Bracho A; González-Candelas F; Navarro D
J Infect; 2022 Apr; 84(4):579-613. PubMed ID: 35016898
[No Abstract] [Full Text] [Related]
63. Protective action of natural and induced immunization against the occurrence of delta or alpha variants of SARS-CoV-2 infection: a test-negative case-control study.
Corrao G; Franchi M; Rea F; Cereda D; Barone A; Borriello CR; Della Valle PG; Ercolanoni M; Fortino I; Jara J; Leoni O; Mazziotta F; Pierini E; Preziosi G; Tirani M; Galli M; Bertolaso G; Pavesi G; Bortolan F
BMC Med; 2022 Feb; 20(1):52. PubMed ID: 35130877
[TBL] [Abstract][Full Text] [Related]
64. The long road.
Cohen J
Science; 2021 Feb; 371(6531):768-772. PubMed ID: 33602838
[No Abstract] [Full Text] [Related]
65. Transmission of SARS-CoV-2 variant B.1.1.7 among vaccinated health care workers.
Ioannou P; Karakonstantis S; Astrinaki E; Saplamidou S; Vitsaxaki E; Hamilos G; Sourvinos G; Kofteridis DP
Infect Dis (Lond); 2021 Nov; 53(11):876-879. PubMed ID: 34176397
[TBL] [Abstract][Full Text] [Related]
66. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
Front Immunol; 2021; 12():802858. PubMed ID: 35003131
[TBL] [Abstract][Full Text] [Related]
67. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
Front Immunol; 2021; 12():690698. PubMed ID: 34276681
[TBL] [Abstract][Full Text] [Related]
68. SARS-CoV-2 infection: Initial viral load (iVL) predicts severity of illness/outcome, and declining trend of iVL in hospitalized patients corresponds with slowing of the pandemic.
El Zein S; Chehab O; Kanj A; Akrawe S; Alkassis S; Mishra T; Shatta M; El-Hor N; Salimnia H; Chandrasekar P
PLoS One; 2021; 16(9):e0255981. PubMed ID: 34529675
[TBL] [Abstract][Full Text] [Related]
69. Association of Demographic, Clinical, and Vaccination Characteristics with COVID-19 Viral Load Assessed by qRT-PCR.
Khorraminejad-Shirazi M; Nabavizadeh SS; Aminnia S; Ahmadifar M; Borazjani R; Sadeghi E; Izadpanah S; Heidari Esfahani M; Mokhtari M; Monabati A
Arch Iran Med; 2023 Dec; 26(12):688-694. PubMed ID: 38431949
[TBL] [Abstract][Full Text] [Related]
70. Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Infectious Virus Loads Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals.
Luo CH; Morris CP; Sachithanandham J; Amadi A; Gaston D; Li M; Swanson NJ; Schwartz M; Klein EY; Pekosz A; Mostafa HH
medRxiv; 2021 Aug; ():. PubMed ID: 34462756
[TBL] [Abstract][Full Text] [Related]
71. Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance - Eight U.S. Locations, December 2020-August 2021.
Fowlkes A; Gaglani M; Groover K; Thiese MS; Tyner H; Ellingson K;
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1167-1169. PubMed ID: 34437521
[TBL] [Abstract][Full Text] [Related]
72. Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021.
Embi PJ; Levy ME; Naleway AL; Patel P; Gaglani M; Natarajan K; Dascomb K; Ong TC; Klein NP; Liao IC; Grannis SJ; Han J; Stenehjem E; Dunne MM; Lewis N; Irving SA; Rao S; McEvoy C; Bozio CH; Murthy K; Dixon BE; Grisel N; Yang DH; Goddard K; Kharbanda AB; Reynolds S; Raiyani C; Fadel WF; Arndorfer J; Rowley EA; Fireman B; Ferdinands J; Valvi NR; Ball SW; Zerbo O; Griggs EP; Mitchell PK; Porter RM; Kiduko SA; Blanton L; Zhuang Y; Steffens A; Reese SE; Olson N; Williams J; Dickerson M; McMorrow M; Schrag SJ; Verani JR; Fry AM; Azziz-Baumgartner E; Barron MA; Thompson MG; DeSilva MB
MMWR Morb Mortal Wkly Rep; 2021 Nov; 70(44):1553-1559. PubMed ID: 34735426
[TBL] [Abstract][Full Text] [Related]
73. SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers.
Rovida F; Cassaniti I; Paolucci S; Percivalle E; Sarasini A; Piralla A; Giardina F; Sammartino JC; Ferrari A; Bergami F; Muzzi A; Novelli V; Meloni A; Cutti S; Grugnetti AM; Grugnetti G; Rona C; Daglio M; Marena C; Triarico A; Lilleri D; Baldanti F
Nat Commun; 2021 Oct; 12(1):6032. PubMed ID: 34654808
[TBL] [Abstract][Full Text] [Related]
74. Impact of inactivated COVID-19 vaccines on lung injury in B.1.617.2 (Delta) variant-infected patients.
Lai M; Wang K; Ding C; Yin Y; Lin X; Xu C; Hu Z; Peng Z
Ann Clin Microbiol Antimicrob; 2023 Mar; 22(1):22. PubMed ID: 36944961
[TBL] [Abstract][Full Text] [Related]
75. Comparison of culture-competent virus shedding duration of SARS-CoV-2 Omicron variant in regard to vaccination status: A prospective cohort study.
Kang SW; Park H; Yeun Kim J; Bae JY; Park MS; Kim SH
Vaccine; 2023 Apr; 41(17):2769-2772. PubMed ID: 37003909
[TBL] [Abstract][Full Text] [Related]
76. Wide Real-Life Data Support Reduced Sensitivity of Antigen Tests for Omicron SARS-CoV-2 Infections.
Piubelli C; Treggiari D; Lavezzari D; Deiana M; Dishnica K; Tosato EMS; Mazzi C; Cattaneo P; Mori A; Pomari E; Nicolini L; Leonardi M; Perandin F; Formenti F; Giorgetti A; Conti A; Capobianchi MR; Gobbi FG; Castilletti C
Viruses; 2024 Apr; 16(5):. PubMed ID: 38793539
[TBL] [Abstract][Full Text] [Related]
77. SARS-CoV-2 innate effector associations and viral load in early nasopharyngeal infection.
Liou TG; Adler FR; Cahill BC; Cox DR; Cox JE; Grant GJ; Hanson KE; Hartsell SC; Hatton ND; Helms MN; Jensen JL; Kartsonaki C; Li Y; Leung DT; Marvin JE; Middleton EA; Osburn-Staker SM; Packer KA; Shakir SM; Sturrock AB; Tardif KD; Warren KJ; Waddoups LJ; Weaver LJ; Zimmerman E; Paine R
Physiol Rep; 2021 Feb; 9(4):e14761. PubMed ID: 33625796
[TBL] [Abstract][Full Text] [Related]
78. Modeling the Transmission of the SARS-CoV-2 Delta Variant in a Partially Vaccinated Population.
Avila-Ponce de León U; Avila-Vales E; Huang K
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062363
[TBL] [Abstract][Full Text] [Related]
79. Infections with the SARS-CoV-2 Delta variant exhibit fourfold increased viral loads in the upper airways compared to Alpha or non-variants of concern.
von Wintersdorff CJH; Dingemans J; van Alphen LB; Wolffs PFG; van der Veer BMJW; Hoebe CJPA; Savelkoul PHM
Sci Rep; 2022 Aug; 12(1):13922. PubMed ID: 35978025
[TBL] [Abstract][Full Text] [Related]
80. Measuring infectious SARS-CoV-2 in clinical samples reveals a higher viral titer:RNA ratio for Delta and Epsilon vs. Alpha variants.
Despres HW; Mills MG; Shirley DJ; Schmidt MM; Huang ML; Roychoudhury P; Jerome KR; Greninger AL; Bruce EA
Proc Natl Acad Sci U S A; 2022 Feb; 119(5):. PubMed ID: 35058348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
